CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer.
暂无分享,去创建一个
[1] J. Ellinger,et al. Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer. , 2008, The Journal of urology.
[2] R. Lothe,et al. The epigenome of testicular germ cell tumors , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[3] M. Fraga,et al. Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN‐1) , 2006, The Journal of pathology.
[4] Qinghua Feng,et al. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] J. Köllermann,et al. Epigenetic silencing of the putative tumor suppressor gene testisin in testicular germ cell tumors , 2006, Journal of Cancer Research and Clinical Oncology.
[6] A. Horwich,et al. Guidelines on testicular cancer. , 2005, European urology.
[7] B. Trock,et al. Preoperative Serum DNA GSTP1 CpG Island Hypermethylation and the Risk of Early Prostate-Specific Antigen Recurrence Following Radical Prostatectomy , 2005, Clinical Cancer Research.
[8] J. Clements,et al. Hypermethylation of the 5′ CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis , 2005, British Journal of Cancer.
[9] J. Bacik,et al. Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors , 2004, Molecular Cancer.
[10] A. Reeve,et al. Multipoint methylation analysis indicates a distinctive epigenetic phenotype among testicular germ cell tumors and testicular malignant lymphomas , 2003, Genes, chromosomes & cancer.
[11] T. Matsuda,et al. Increasing incidence of testicular cancer worldwide: a review. , 2003, The Journal of urology.
[12] E. Maher,et al. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours , 2003, Oncogene.
[13] R. Lothe,et al. Frequent promoter hypermethylation of the O6-Methylguanine-DNA Methyltransferase (MGMT) gene in testicular cancer , 2002, Oncogene.
[14] V. Reuter,et al. Characteristic promoter hypermethylation signatures in male germ cell tumors , 2002, Molecular Cancer.
[15] C. Plass,et al. Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors , 2002, Oncogene.
[16] F. O. Fackelmayer,et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. , 2001, Cancer research.
[17] L. Guillou,et al. Frequent p16INK4 (MTS1) gene inactivation in testicular germ cell tumors. , 1997, The American journal of pathology.
[18] P. Albers,et al. Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer. , 2009, The Journal of urology.
[19] R. Fimmers,et al. Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators , 2008, International journal of cancer.
[20] R. Salazar,et al. Tumor markers at the time of recurrence in patients with germ cell tumors , 2000, Cancer.